Alto Ingredients, Inc. (NASDAQ:ALTO - Free Report) - Equities research analysts at HC Wainwright cut their FY2025 earnings per share (EPS) estimates for Alto Ingredients in a research report issued to clients and investors on Thursday, March 6th. HC Wainwright analyst A. Dayal now forecasts that the company will earn ($0.27) per share for the year, down from their prior estimate of $0.34. HC Wainwright currently has a "Buy" rating and a $5.50 target price on the stock. The consensus estimate for Alto Ingredients' current full-year earnings is ($0.37) per share.
Alto Ingredients Trading Down 5.6 %
Alto Ingredients stock traded down $0.08 during trading hours on Monday, reaching $1.31. The stock had a trading volume of 383,090 shares, compared to its average volume of 652,075. The stock has a market cap of $100.56 million, a PE ratio of -2.52 and a beta of 1.73. The company has a fifty day simple moving average of $1.63 and a 200-day simple moving average of $1.58. The company has a debt-to-equity ratio of 0.32, a current ratio of 3.22 and a quick ratio of 2.15. Alto Ingredients has a 52 week low of $1.18 and a 52 week high of $2.40.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of ALTO. D. E. Shaw & Co. Inc. increased its stake in shares of Alto Ingredients by 20.7% during the fourth quarter. D. E. Shaw & Co. Inc. now owns 1,601,379 shares of the company's stock valued at $2,498,000 after buying an additional 274,918 shares during the period. Peapod Lane Capital LLC bought a new position in Alto Ingredients in the 4th quarter worth $1,465,000. Geode Capital Management LLC raised its holdings in Alto Ingredients by 1.0% in the 4th quarter. Geode Capital Management LLC now owns 893,951 shares of the company's stock worth $1,395,000 after purchasing an additional 8,435 shares in the last quarter. Jane Street Group LLC lifted its position in shares of Alto Ingredients by 39.9% in the 4th quarter. Jane Street Group LLC now owns 405,182 shares of the company's stock worth $632,000 after purchasing an additional 115,578 shares during the period. Finally, The Manufacturers Life Insurance Company boosted its stake in shares of Alto Ingredients by 5.4% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 370,852 shares of the company's stock valued at $597,000 after purchasing an additional 19,104 shares in the last quarter. Hedge funds and other institutional investors own 42.44% of the company's stock.
About Alto Ingredients
(
Get Free Report)
Alto Ingredients, Inc produces, distributes, and markets specialty alcohols, renewable fuel, and essential ingredients in the United States. The company operates in three segments: Marketing and Distribution, Pekin Campus Production, and Western Production. It offers specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants, and cleaners for health, home, and beauty markets; grain neutral spirits used in alcoholic beverages and vinegar, as well as corn germ used in corn oils in the food and beverage markets; alcohols and other products for paint applications and fertilizers in the industrial and agriculture markets; and essential ingredients include dried yeast, corn protein meal, corn protein feed, distiller's grains, and liquid feed for commercial animal feed and pet food applications, as well as yeast for human consumption.
Recommended Stories
Before you consider Alto Ingredients, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alto Ingredients wasn't on the list.
While Alto Ingredients currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.